Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

The helminth-derived peptide GK-1 induces an anti-tumoral CD8 T cell response associated with downregulation of the PD-1/PD-L1 pathway.

Rodríguez-Rodríguez N, Madera-Salcedo IK, Bugarin-Estrada E, Sánchez-Miranda E, Torres-García D, Cervantes-Torres J, Fragoso G, Rosetti F, Crispín JC, Sciutto E.

Clin Immunol. 2019 Jul 9. pii: S1521-6616(19)30163-9. doi: 10.1016/j.clim.2019.07.006. [Epub ahead of print]

PMID:
31299381
2.

Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials.

Morabito A, Piccirillo MC, Maione P, Luciani A, Cavanna L, Bonanno L, Filipazzi V, Leo S, Cinieri S, Morgillo F, Burgio MA, Ferrara D, Rosetti F, Bianco R, Artioli F, Cortinovis D, Gebbia V, Fregoni V, Mencoboni M, Sandomenico C, Rossi A, Montanino A, Manzo A, Rocco G, Arenare L, Daniele G, Signoriello S, Gallo C, Perrone F, Gridelli C.

Lung Cancer. 2019 Jul;133:62-68. doi: 10.1016/j.lungcan.2019.05.009. Epub 2019 May 9.

PMID:
31200830
3.

From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study).

Pasello G, Vicario G, Zustovich F, Oniga F, Gori S, Rosetti F, Bonetti A, Favaretto A, Toso S, Redelotti R, Santo A, Bernardi D, Giovanis P, Oliani C, Calvetti L, Gatti C, Palazzolo G, Baretta Z, Bortolami A, Bonanno L, Basso M, Menis J, Corte DD, Frega S, Guarneri V, Conte P; Veneto Oncology Network.

Oncologist. 2019 Jun;24(6):e318-e326. doi: 10.1634/theoncologist.2018-0712. Epub 2019 Mar 7.

PMID:
30846513
4.

Gene-function studies in systemic lupus erythematosus.

Rosetti F, de la Cruz A, Crispín JC.

Curr Opin Rheumatol. 2019 Mar;31(2):185-192. doi: 10.1097/BOR.0000000000000572.

PMID:
30672908
5.

Gene-function studies in SLE.

Rosetti F, de la Cruz A, Crispín JC.

Curr Opin Rheumatol. 2018 Dec 11. doi: 10.1097/BOR.0000000000000572. [Epub ahead of print]

PMID:
30540578
6.

Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial.

Nanni O, Amadori D, De Censi A, Rocca A, Freschi A, Bologna A, Gianni L, Rosetti F, Amaducci L, Cavanna L, Foca F, Sarti S, Serra P, Valmorri L, Bruzzi P, Corradengo D, Gennari A; MYME investigators.

Breast Cancer Res Treat. 2019 Apr;174(2):433-442. doi: 10.1007/s10549-018-05070-2. Epub 2018 Dec 7.

PMID:
30536182
7.

Cis interaction between sialylated FcγRIIA and the αI-domain of Mac-1 limits antibody-mediated neutrophil recruitment.

Saggu G, Okubo K, Chen Y, Vattepu R, Tsuboi N, Rosetti F, Cullere X, Washburn N, Tahir S, Rosado AM, Holland SM, Anthony RM, Sen M, Zhu C, Mayadas TN.

Nat Commun. 2018 Nov 29;9(1):5058. doi: 10.1038/s41467-018-07506-1.

8.

Metronomic oral vinorelbine for the treatment of advanced non-small cell lung cancer: a multicenter international retrospective analysis.

Camerini A, Banna GL, Cinieri S, Pezzuto A, Mencoboni M, Rosetti F, Figueiredo A, Rizzo P, Ricci A, Langenhoven L, Santo A, Addeo A, Amoroso D, Barata F.

Clin Transl Oncol. 2019 Jun;21(6):790-795. doi: 10.1007/s12094-018-1989-y. Epub 2018 Nov 17.

PMID:
30448956
9.

Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials.

Gridelli C, Morabito A, Cavanna L, Luciani A, Maione P, Bonanno L, Filipazzi V, Leo S, Cinieri S, Ciardiello F, Burgio MA, Bilancia D, Cortinovis D, Rosetti F, Bianco R, Gebbia V, Artioli F, Bordonaro R, Fregoni V, Mencoboni M, Nelli F, Riccardi F, di Isernia G, Costanzo R, Rocco G, Daniele G, Signoriello S, Piccirillo MC, Gallo C, Perrone F.

J Clin Oncol. 2018 Sep 1;36(25):2585-2592. doi: 10.1200/JCO.2017.76.8390. Epub 2018 Jul 20.

PMID:
30028656
10.

Mechanisms of Tissue Injury in Lupus Nephritis.

Flores-Mendoza G, Sansón SP, Rodríguez-Castro S, Crispín JC, Rosetti F.

Trends Mol Med. 2018 Apr;24(4):364-378. doi: 10.1016/j.molmed.2018.02.003. Epub 2018 Mar 8. Review.

PMID:
29526595
11.

Intrathecal anti-suprabasin antibodies in SLE, a cause of local concern?

Rosetti F, Crispín JC.

Clin Immunol. 2018 Aug;193:131-132. doi: 10.1016/j.clim.2017.11.013. Epub 2017 Nov 29. No abstract available.

PMID:
29197637
12.

Neutrophil FcγRIIA promotes IgG-mediated glomerular neutrophil capture via Abl/Src kinases.

Nishi H, Furuhashi K, Cullere X, Saggu G, Miller MJ, Chen Y, Rosetti F, Hamilton SL, Yang L, Pittman SP, Liao J, Herter JM, Berry JC, DeAngelo DJ, Zhu C, Tsokos GC, Mayadas TN.

J Clin Invest. 2017 Oct 2;127(10):3810-3826. doi: 10.1172/JCI94039. Epub 2017 Sep 11.

13.

Lupus and proliferative nephritis are PAD4 independent in murine models.

Gordon RA, Herter JM, Rosetti F, Campbell AM, Nishi H, Kashgarian M, Bastacky SI, Marinov A, Nickerson KM, Mayadas TN, Shlomchik MJ.

JCI Insight. 2017 May 18;2(10). pii: 92926. doi: 10.1172/jci.insight.92926. eCollection 2017 May 18.

14.

Patients' Attitudes and Physicians' Perceptions Toward Maintenance Therapy for Advanced Non-Small-cell Lung Cancer: A Multicenter Italian Survey.

Pacchiana MV, Capelletto E, Carnio S, Gridelli C, Rossi A, Galetta D, Montagna ES, Bordi P, Ceribelli A, Cortinovis D, Scotti V, Martelli O, Valmadre G, Del Conte A, Miccianza A, Morena R, Rosetti F, Di Maio M, Ostacoli L, Novello S.

Clin Lung Cancer. 2017 Jul;18(4):381-387. doi: 10.1016/j.cllc.2016.10.002. Epub 2016 Nov 22.

PMID:
27965013
15.

ICER is requisite for Th17 differentiation.

Yoshida N, Comte D, Mizui M, Otomo K, Rosetti F, Mayadas TN, Crispín JC, Bradley SJ, Koga T, Kono M, Karampetsou MP, Kyttaris VC, Tenbrock K, Tsokos GC.

Nat Commun. 2016 Sep 29;7:12993. doi: 10.1038/ncomms12993.

16.

The many faces of Mac-1 in autoimmune disease.

Rosetti F, Mayadas TN.

Immunol Rev. 2016 Jan;269(1):175-93. doi: 10.1111/imr.12373. Review.

PMID:
26683153
17.

AKAP9 regulates activation-induced retention of T lymphocytes at sites of inflammation.

Herter JM, Grabie N, Cullere X, Azcutia V, Rosetti F, Bennett P, Herter-Sprie GS, Elyaman W, Luscinskas FW, Lichtman AH, Mayadas TN.

Nat Commun. 2015 Dec 18;6:10182. doi: 10.1038/ncomms10182.

18.

A Lupus-Associated Mac-1 Variant Has Defects in Integrin Allostery and Interaction with Ligands under Force.

Rosetti F, Chen Y, Sen M, Thayer E, Azcutia V, Herter JM, Luscinskas FW, Cullere X, Zhu C, Mayadas TN.

Cell Rep. 2015 Mar 17;10(10):1655-1664. doi: 10.1016/j.celrep.2015.02.037. Epub 2015 Mar 12.

19.

The mechanisms of up-regulation of dendritic cell activity by oxidative stress.

Batal I, Azzi J, Mounayar M, Abdoli R, Moore R, Lee JY, Rosetti F, Wang C, Fiorina P, Sackstein R, Ichimura T, Abdi R.

J Leukoc Biol. 2014 Aug;96(2):283-93. doi: 10.1189/jlb.3A0113-033RR. Epub 2014 Mar 27.

20.

Endothelial TNF receptor 2 induces IRF1 transcription factor-dependent interferon-β autocrine signaling to promote monocyte recruitment.

Venkatesh D, Ernandez T, Rosetti F, Batal I, Cullere X, Luscinskas FW, Zhang Y, Stavrakis G, García-Cardeña G, Horwitz BH, Mayadas TN.

Immunity. 2013 May 23;38(5):1025-37. doi: 10.1016/j.immuni.2013.01.012. Epub 2013 Apr 25.

21.

Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience.

Bearz A, Talamini R, Rossoni G, Santo A, de Pangher V, Fasola G, Rosetti F, Favaretto A, Gregorc V, Berretta M, Santarossa S, Berto E, Tirelli U.

BMC Res Notes. 2012 Sep 3;5:482. doi: 10.1186/1756-0500-5-482.

22.

Human lupus serum induces neutrophil-mediated organ damage in mice that is enabled by Mac-1 deficiency.

Rosetti F, Tsuboi N, Chen K, Nishi H, Ernandez T, Sethi S, Croce K, Stavrakis G, Alcocer-Varela J, Gómez-Martin D, van Rooijen N, Kyttaris VC, Lichtman AH, Tsokos GC, Mayadas TN.

J Immunol. 2012 Oct 1;189(7):3714-23. Epub 2012 Aug 29.

23.

Cutting edge: protein phosphatase 2A confers susceptibility to autoimmune disease through an IL-17-dependent mechanism.

Crispín JC, Apostolidis SA, Rosetti F, Keszei M, Wang N, Terhorst C, Mayadas TN, Tsokos GC.

J Immunol. 2012 Apr 15;188(8):3567-71. doi: 10.4049/jimmunol.1200143. Epub 2012 Mar 14.

24.

Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes.

Gohda T, Niewczas MA, Ficociello LH, Walker WH, Skupien J, Rosetti F, Cullere X, Johnson AC, Crabtree G, Smiles AM, Mayadas TN, Warram JH, Krolewski AS.

J Am Soc Nephrol. 2012 Mar;23(3):516-24. doi: 10.1681/ASN.2011060628. Epub 2012 Jan 19.

25.

Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes.

Niewczas MA, Gohda T, Skupien J, Smiles AM, Walker WH, Rosetti F, Cullere X, Eckfeldt JH, Doria A, Mayadas TN, Warram JH, Krolewski AS.

J Am Soc Nephrol. 2012 Mar;23(3):507-15. doi: 10.1681/ASN.2011060627. Epub 2012 Jan 19.

26.

Neutrophils: game changers in glomerulonephritis?

Mayadas TN, Rosetti F, Ernandez T, Sethi S.

Trends Mol Med. 2010 Aug;16(8):368-78. doi: 10.1016/j.molmed.2010.06.002. Epub 2010 Jul 29. Review.

27.

Impact of third-generation drugs on the activity of first-line chemotherapy in advanced non-small cell lung cancer: a meta-analytical approach.

Grossi F, Aita M, Defferrari C, Rosetti F, Brianti A, Fasola G, Vinante O, Pronzato P, Pappagallo G.

Oncologist. 2009 May;14(5):497-510. doi: 10.1634/theoncologist.2008-0260. Epub 2009 May 7.

28.

T cell apoptosis at the maternal-fetal interface in early human pregnancy, involvement of galectin-1.

Kopcow HD, Rosetti F, Leung Y, Allan DS, Kutok JL, Strominger JL.

Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18472-7. doi: 10.1073/pnas.0809233105. Epub 2008 Nov 14.

29.

Human and porcine neurocysticercosis: differences in the distribution and developmental stages of cysticerci.

Sáenz B, Ramírez J, Aluja A, Escobar A, Fragoso G, Morales J, Pérez-Tamayo R, Rosetti F, Larralde C, Sciutto E, Fleury A.

Trop Med Int Health. 2008 May;13(5):697-702. doi: 10.1111/j.1365-3156.2008.02059.x. Epub 2008 Mar 31.

30.

Human neurocysticercosis: rightward hemisphere asymmetry in the cerebral distribution of a single cysticercus.

Romero R, Saenz B, Rosetti F, Perez-Tamayo R, Fragoso G, Huerta M, Arcega-Revilla R, Larralde C, Sciutto E, Fleury A.

J Parasitol. 2007 Oct;93(5):1238-40. doi: 10.1645/GE-1110R.1.

PMID:
18163368
31.

Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study.

Gridelli C, Gallo C, Ceribelli A, Gebbia V, Gamucci T, Ciardiello F, Carozza F, Favaretto A, Daniele B, Galetta D, Barbera S, Rosetti F, Rossi A, Maione P, Cognetti F, Testa A, Di Maio M, Morabito A, Perrone F; GECO investigators.

Lancet Oncol. 2007 Jun;8(6):500-12.

PMID:
17513173
32.

HLA-DR association with the genetic susceptibility to develop ashy dermatosis in Mexican Mestizo patients.

Correa MC, Memije EV, Vargas-Alarcón G, Guzmán RA, Rosetti F, Acuña-Alonzo V, Martínez-Rodríguez N, Granados J.

J Am Acad Dermatol. 2007 Apr;56(4):617-20. Epub 2006 Nov 20.

PMID:
17116345
33.

[Influence of alleles and haplotypes of the main histocompatibility complex on the susceptibility to systemic lupus erythematosus in the Mexican population].

Granados J, Zúñiga J, Acuña-Alonzo V, Rosetti F, Vargas-Alarcón G.

Gac Med Mex. 2006 May-Jun;142(3):195-9. Spanish.

PMID:
16875346
34.

Allele frequencies for 15 autosomal STR loci and admixture estimates in Puerto Rican Americans.

Zúñiga J, Ilzarbe M, Acunha-Alonzo V, Rosetti F, Herbert Z, Romero V, Almeciga I, Clavijo O, Stern JN, Granados J, Fridkis-Hareli M, Morrison P, Azocar J, Yunis EJ.

Forensic Sci Int. 2006 Dec 20;164(2-3):266-70. Epub 2006 Jan 19.

PMID:
16426785
35.

A novel synthetic adjuvant effectively enhances the immunogenicity of the influenza vaccine.

Segura-Velázquez R, Pérez-Torres A, Rosas G, Toledo A, Restelli M, Acosta E, Corral R, Rosetti F, Fragoso G, Grinstein S, Sciutto E.

Vaccine. 2006 Feb 20;24(8):1073-80. Epub 2005 Sep 20.

PMID:
16202486
36.

Diclofenac salts. III. Alkaline and earth alkaline salts.

Fini A, Fazio G, Rosetti F, Angeles Holgado M, Iruín A, Alvarez-Fuentes J.

J Pharm Sci. 2005 Nov;94(11):2416-31.

PMID:
16200614
37.

Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study.

Maione P, Perrone F, Gallo C, Manzione L, Piantedosi F, Barbera S, Cigolari S, Rosetti F, Piazza E, Robbiati SF, Bertetto O, Novello S, Migliorino MR, Favaretto A, Spatafora M, Ferraù F, Frontini L, Bearz A, Repetto L, Gridelli C, Barletta E, Barzelloni ML, Iaffaioli RV, De Maio E, Di Maio M, De Feo G, Sigoriello G, Chiodini P, Cioffi A, Guardasole V, Angelini V, Rossi A, Bilancia D, Germano D, Lamberti A, Pontillo V, Brancaccio L, Renda F, Romano F, Esani G, Gambaro A, Vinante O, Azzarello G, Clerici M, Bollina R, Belloni P, Sannicolò M, Ciuffreda L, Parello G, Cabiddu M, Sacco C, Sibau A, Porcile G, Castiglione F, Ostellino O, Monfardini S, Stefani M, Scagliotti G, Selvaggi G, De Marinis F, Martelli O, Gasparini G, Morabito A, Gattuso D, Colucci G, Galetta D, Giotta F, Gebbia V, Borsellino N, Testa A, Malaponte E, Capuano MA, Angiolillo M, Sollitto F, Tirelli U, Spazzapan S, Adamo V, Altavilla G, Scimone A, Hopps MR, Tartamella F, Ianniello GP, Tinessa V, Failla G, Bordonaro R, Gebbia N, Valerio MR, D'Aprile M, Veltri E, Tonato M, Darwish S, Romito S, Carrozza F, Barni S, Ardizzoia A, Corradini GM, Pavia G, Belli M, Colantuoni G, Galligioni E, Caffo O, Labianca R, Quadri A, Cortesi E, D'Auria G, Fava S, Calcagno A, Luporini G, Locatelli MC, Di Costanzo F, Gasperoni S, Isa L, Candido P, Gaion F, Palazzolo G, Nettis G, Annamaria A, Rinaldi M, Lopez M, Felletti R, Di Negro GB, Rossi N, Calandriello A, Maiorino L, Mattioli R, Celano A, Schiavon S, Illiano A, Raucci CA, Caruso M, Foa P, Tonini G, Curcio C, Cazzaniga M.

J Clin Oncol. 2005 Oct 1;23(28):6865-72.

38.

Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials.

Di Maio M, Gridelli C, Gallo C, Shepherd F, Piantedosi FV, Cigolari S, Manzione L, Illiano A, Barbera S, Robbiati SF, Frontini L, Piazza E, Ianniello GP, Veltri E, Castiglione F, Rosetti F, Gebbia V, Seymour L, Chiodini P, Perrone F.

Lancet Oncol. 2005 Sep;6(9):669-77. Review.

PMID:
16129367
39.

Thermal and fractal analysis of diclofenac/Gelucire 50/13 microparticles obtained by ultrasound-assisted atomization.

Cavallari C, Rodriguez L, Albertini B, Passerini N, Rosetti F, Fini A.

J Pharm Sci. 2005 May;94(5):1124-34.

PMID:
15793806
40.

Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer.

Di Maio M, Gridelli C, Gallo C, Manzione L, Brancaccio L, Barbera S, Robbiati SF, Ianniello GP, Ferraù F, Piazza E, Frontini L, Rosetti F, Carrozza F, Bearz A, Spatafora M, Adamo V, Isa L, Iaffaioli RV, Di Salvo E, Perrone F.

Br J Cancer. 2004 Jun 14;90(12):2288-96.

41.

Supportive care in patients with advanced non-small-cell lung cancer.

Di Maio M, Perrone F, Gallo C, Iaffaioli RV, Manzione L, Piantedosi FV, Cigolari S, Illiano A, Barbera S, Robbiati SF, Piazza E, Ianniello GP, Frontini L, Veltri E, Castiglione F, Rosetti F, De Maio E, Maione P, Gridelli C, Rossi A, Barletta E, Barzelloni ML, Signoriello G, Bilancia D, Dinota A, Rosati G, Germano D, Lamberti A, Pontillo V, Brancacio L, Crispino C, Esposito M, Battiloro C, Tufano G, Cioffi A, Guardasole V, Angelini V, Guidetti G, Barbera S, Renda F, Romano F, Volpintesta A, Robbiati SF, Sannicolò M, Filipazzi V, Esani G, Gambaro A, Ferrario S, Tinessa V, Caprio MG, Zonato S, Cabiddu M, Raina A, Veltri E, D'Aprile M, Pistillucci G, Porcile G, Ostellino O, Vinante O, Azzarello G, Gebbia V, Borsellino N, Testa A, Gasparini G, Morabito A, Gattuso D, Romito S, Carrozza F, Fava S, Calcagno A, Grimi E, Bertetto O, Ciuffreda L, Parello G, Maiorino L, Santoro A, Santoro M, Failla G, Aiello RA, Bearz A, Sorio R, Scalone S, Clerici M, Bollina R, Belloni P, Sacco C, Sibau A, Adamo V, Altavilla G, Scimone A, Spatafora M, Bellia V, Hopps MR, Monfardini S, Favaretto A, Stefani M, Corradini GM, Pavia G, Scagliotti G, Novello S, Selvaggi G, Tonato M, Darwish S, Michetti G, Belometti MO, Labianca R, Quadri A, De Marinis F, Migliorino MR, Martelli O, Colucci G, Galetta D, Giotta F, Isa L, Candido P, Rossi N, Calandriello A, Ferraù F, Malaponte E, Barni S, Cazzaniga M, Gebbia N, Valerio MR, Belli M, Colantuoni G, Capuano MA, Angiolillo M, Sollitto F, Ardizzoia A, Luporini G, Locatelli MC, Pari F, Aitini E, Pedicini T, Febbraro A, Zollo C, Di Costanzo F, Bartolucci R, Gasperoni S, Gaion F, Palazzolo G, Galligioni E, Caffo O, Cortesi E, D'Auria G, Curcio C, Vasta M, Bumma C, Celano A, Bretti S, Nettis G, Anselmo A, Mattioli R, Nisticò C, Aschelter A, Foa P.

Br J Cancer. 2003 Sep 15;89(6):1013-21.

42.

Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.

Gridelli C, Perrone F, Gallo C, Cigolari S, Rossi A, Piantedosi F, Barbera S, Ferraù F, Piazza E, Rosetti F, Clerici M, Bertetto O, Robbiati SF, Frontini L, Sacco C, Castiglione F, Favaretto A, Novello S, Migliorino MR, Gasparini G, Galetta D, Iaffaioli RV, Gebbia V; MILES Investigators.

J Natl Cancer Inst. 2003 Mar 5;95(5):362-72.

PMID:
12618501
43.

The impact of progenitor enrichment, serum, and cytokines on the ex vivo expansion of mobilized peripheral blood stem cells: a controlled trial.

Balducci E, Azzarello G, Valenti MT, Capuzzo GM, Pappagallo GL, Pilotti I, Ausoni S, Bari M, Rosetti F, Sartori D, Ciappa A, Porcellini A, Vinante O.

Stem Cells. 2003;21(1):33-40.

44.

Hypnosis in the treatment of anticipatory nausea and vomiting in patients receiving cancer chemotherapy.

Marchioro G, Azzarello G, Viviani F, Barbato F, Pavanetto M, Rosetti F, Pappagallo GL, Vinante O.

Oncology. 2000 Aug;59(2):100-4.

PMID:
10971166
45.

Outbreak of type A botulism and development of a botulism surveillance and antitoxin release system in Argentina.

Villar RG, Shapiro RL, Busto S, Riva-Posse C, Verdejo G, Farace MI, Rosetti F, San Juan JA, Julia CM, Becher J, Maslanka SE, Swerdlow DL.

JAMA. 1999 Apr 14;281(14):1334-8, 1340.

PMID:
10208152
46.

The impact of a psychological intervention on quality of life in non-metastatic breast cancer.

Marchioro G, Azzarello G, Checchin F, Perale M, Segati R, Sampognaro E, Rosetti F, Franchin A, Pappagallo GL, Vinante O.

Eur J Cancer. 1996 Aug;32A(9):1612-5.

PMID:
8911127
47.

Safety of first trimester exposure to histamine H2 blockers. A prospective cohort study.

Magee LA, Inocencion G, Kamboj L, Rosetti F, Koren G.

Dig Dis Sci. 1996 Jun;41(6):1145-9.

PMID:
8654145
48.

Glial fibrillary acidic protein (GFAP) immunochemical profile after junin virus infection of rat cultured astrocytes.

Iacono RF, Nessi de Aviñón A, Rosetti FA, Berría MI.

Neurosci Lett. 1995 Nov 24;200(3):175-8.

PMID:
9064605
49.

The combination of mitomycin, vinblastine and cisplatin is active in the palliation of stage IIIB-IV non-small-cell lung cancer.

Vinante O, Bari M, Segati R, Azzarello G, Sampognaro E, Rosetti F, Pappagallo GL.

Oncology. 1993;50(1):1-4.

PMID:
8380631
50.

[Evaluation of alternative hemoculture tests for the diagnosis of early neonatal sepsis].

Celadilla ML, Rosetti FA, Ochoa LB, Forgione H, Cohen A, Nejamkis MR.

Medicina (B Aires). 1993;53(2):124-8. Spanish.

PMID:
8295528

Supplemental Content

Loading ...
Support Center